Glucosamine Research Page2

Glucosamine Research (page 2)

Double-Blind Clinical Evaluation of the Relative Efficacy of Ibuprofen and Glucosamine
Ibuprofen (an NSAID) and glucosamine were given in a double-blind clinical study, to evaluate them side by side. While the Ibuprofen was initially more effective at easing pain, the glucosamine quickly surpassed the ibuprofen and continued to reduce pain over a longer period of time, while the doses remained the same.

Efficacy and Safety of Glucosamine in Osteoarthritis of the Spine
There was more improvement with the patients who used the glucosamine versus the placebo group. The patients also reported less pain, less stiffness, and better mobility when using glucosamine. In addition, the glucosamine effects lasted beyond the study, suggesting a carryover effect that lasts even after glucosamine is discontinued.

Oral Glucosamine in the Management of Arthritis
Shows that glucosamine therapy resulted in a reduction in symptoms of pain while at rest, pain when rising from a seated or lying position and pain during movement or exercise. Effects persisted for a period of time after treatment, suggesting that glucosamine therapy has more than just anti-inflammatory properties.

Glucosamine Decreases Progression of Knee Osteoarthritis
Those patients who received glucosamine had reduced levels of pain and very little to no joint space narrowing at the conclusion of the study. Glucosamine then can be considered effective at helping to prevent the joint space narrowing associated with osteoarthritis.

Glucosamine in Osteoarthritis of the Knee
This clinical study went all out with a multicenter, randomized, placebo-controlled, double-blind, parallel-group study design. The glucosamine group showed a greater decrease in pain than placebo, with negligible side effects.

Glucosamine Significantly Reduces Progression of Knee Osteoarthritis
Glucosamine was administered to half of the patients (1500 mg a day for three years) and the other half was on placebo. In the glucosamine group, no joint narrowing was observed, whereas the control group was narrowing at a rate of .08 to .1 mm per year. The glucosamine group improved their symptoms while the placebo group’s symptoms gradually became worse.

Correlation Between Radiographic Severity of Knee Osteoarthritis and Future Disease Progression
The joint space narrowing was significantly less for those patients who took the glucosamine (verses placebo). There was also a reduction in the joint space narrowing for those who took glucosamine. This suggests that those patients who have arthritis and are experiencing joint space narrowing would benefit from glucosamine treatments which aid in minimizing and repairing this problem.

For more Clinical Studies, continue on to the Glucosamine Research Page 3

Be sure to visit the Glucosamine Product Guide for a review of commercially available glucosamine products broken down by 9 different categories such as price per month, quality and type. Learn what the best products out there are and how we ranked each.